Following the patent expiry, 35+ companies worldwide have launched generic versions, with over half originating from China and India
USA 106 , 12851290 (2009)
Genetics alone doesnt cause HS, and the same lifestyle factors alone wont cause it for everyone
Our commitment is to deliver trustworthy treatment options that empower long-term health
Intragastric balloon therapy Intragastric balloon (IGB) therapy has become an attractive tool for weight loss, owing to its sustained efficacy, low complication rate, and broad application, extending to class I and II obesity
Comment: The applicant noted that, after FDA authorization, it changed the devices' names from aprevo Cervical ACDF system and aprevo Cervical ACDF-X system to aprevo Cervical ACDF interbody and aprevo Cervical ACDF-X interbody, respectively